Teva Brings In Ranibizumab Biosimilar As Bioeq Files In Europe

Israeli Firm Announces Broader Commercialization Agreement For Lucentis Rival

 
• By Dean Rudge
  
EuropeSpace
Europe is among regions where Teva will market ranibiziumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products